# Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin

> **NCT03857399** · PHASE2 · COMPLETED · sponsor: **Cttq** · enrollment: 32 (actual)

## Conditions studied

- Fungal Infection

## Interventions

- **DRUG:** Caspofungin

## Key facts

- **NCT ID:** NCT03857399
- **Lead sponsor:** Cttq
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-17
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857399, "Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT03857399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*